ArticleGenes & diseases2024

Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease.

Souvik Kar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.